Skip to main content
. 2021 Oct 6;45(2):1041–1088. doi: 10.1007/s10143-021-01579-1

Table 2.

Top 100 cited articles on ependymoma by average citations per year

Rank by total citations Rank by average citations per year Title Authors (first and last) Journal title Publication year Total citations Average citations per year Country Type of study
3 1 Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups Pajtler KW, Pfister SM Cancer Cell 2015 321 53.5 Germany Basic science
5 2 C11orf95-RELA fusions drive oncogenic Nf-kappa B signalling in ependymoma Parker M, Gilbertson RJ Nature 2014 272 38.86 USA Basic science
1 3 Radial glia cells are candidate stem cells of ependymoma Taylor MD, Gilbertson RJ Cancer Cell 2005 551 34.44 USA Basic science
7 4 Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma Witt H, Pfister SM Cancer Cell 2011 244 24.4 Germany Basic science
50 5 The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants Pajtler KW, Taylor MD Acta Neuropathologica 2017 89 22.25 Germany Review
6 6 Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study Merchant TE, Sanford RA Lancet Oncology 2009 258 21.5 USA Clinical
9 7 Cross-species genomics matches driver mutations and cell compartments to model ependymoma Johnson RA, Gilbertson RJ Nature 2010 219 19.91 USA Basic science
2 8 Intramedullary ependymoma of the spinal cord Mccormick PC, Stein BM Journal of Neurosurgery 1990 453 14.61 USA Clinical
82 9 Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma Peeler CR, Grosshans DR Radiotherapy and Oncology 2016 65 13 USA Clinical
83 10 Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis Ramaswamy V, Taylor MD Journal of Clinical Oncology 2016 65 13 Canada Clinical
30 11 Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts Ellison DW, Grundy RG Journal of Negative Results in Biomedicine 2011 123 12.3 USA Clinical
11 12 Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma Merchant TE, Sanford RA Journal of Clinical Oncology 2004 201 11.82 USA Clinical
35 13 Molecular staging of intracranial ependymoma in children and adults Korshunov A, Pfister SM Journal of Clinical Oncology 2010 119 10.82 Germany Basic science
14 14 Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics Modena P, Sozzi G Journal of Clinical Oncology 2006 160 10.67 Italy Basic science
15 15 Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma Mendrzyk F, Lichter P Clinical Cancer Research 2006 156 10.4 Germany Basic science
23 16 Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study Grundy RG, Machin D Lancet Oncology 2007 139 9.93 UK Clinical
27 17 Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons Macdonald SM, Yock T International Journal of Radiation Oncology Biology Physics 2008 126 9.69 USA Clinical
69 18 Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients Macdonald SM, Yock TI Neuro-Oncology 2013 76 9.5 USA Clinical
38 19 Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study clinical article Mcguire CS, Fisher PG Journal of Neurosurgery 2009 112 9.33 USA Clinical
63 20 A prognostic gene expression signature in infratentorial ependymoma Wani K, Aldape K Acta Neuropathologica 2012 78 8.67 USA Basic science
13 21 Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French society of pediatric oncology Grill J, Kalifa C Journal of Clinical Oncology 2001 173 8.65 France Clinical
42 22 Pediatric ependymoma: biological perspectives Kilday JP, Grundy R Molecular Cancer Research 2009 101 8.42 UK Review
100 23 Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma Broniscer A, Ellison DW Neuropathology and Applied Neurobiology 2014 58 8.29 USA Clinical
57 24 Identification of microRNAs as potential prognostic markers in ependymoma Costa FF Soares MB Plos One 2011 80 8 USA Basic science
10 25 Natural simian-virus-40 strains are present in human choroid-plexus and ependymoma tumors Lednicky JA, Butel JS Virology 1995 206 7.92 USA Basic science
32 26 Monomorphous angiocentric glioma: a distinctive epileptogenic neoplasm with features of infiltrating astrocytoma and ependymoma Wang M, Burger PC Journal of Neuropathology and Experimental Neurology 2005 121 7.56 USA Clinical
46 27 A retrospective study of surgery and reirradiation for recurrent ependymoma Merchant TE, Sanford RA International Journal of Radiation Oncology Biology Physics 2008 96 7.38 USA Clinical
74 28 An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma Atkinson JM, Gilbertson RJ Cancer Cell 2011 71 7.1 USA Basic science
16 29 Molecular genetic analysis of ependymal tumors: Nf2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas Ebert C, Von Deimling A American Journal of Pathology 1999 154 7 USA Basic science
88 30 Survival benefit for pediatric patients with recurrent ependymoma treated with reirradiation Bouffet E, Tabori U International Journal of Radiation Oncology Biology Physics 2012 62 6.89 Canada Clinical
55 31 Both location and age predict survival in ependymoma: a seer study Mcguire CS, Fisher PG Pediatric Blood & Cancer 2009 81 6.75 USA Clinical
26 32 Spinal cord ependymoma: radical surgical resection and outcome Hanbali F, Gokaslan ZL Neurosurgery 2002 127 6.68 USA Clinical
4 33 Ependymoma: follow-up-study of 101 cases Mork SJ, Loken AC Cancer 1977 290 6.59 Norway Clinical
18 34 Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma Chan AS, Chung LP American Journal of Surgical Pathology 1998 151 6.57 Hong Kong Basic science
31 35 Erbb receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease Gilbertson RJ Ellison DW Clinical Cancer Research 2002 123 6.47 USA Basic science
49 36 Ependymoma Reni M, Vecht C Critical Reviews in Oncology Hematology 2007 90 6.43 Italy Review
54 37 Predicting change in academic abilities after conformal radiation therapy for localized ependymoma Conklin HM, Merchant TE Journal of Clinical Oncology 2008 83 6.38 USA Clinical
8 38 Myxopapillary ependymoma: a clinicopathologic and immunocytochemical study of 77 cases Sonneland PR, Onofrio BM Cancer 1985 226 6.28 USA Clinical
58 39 Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective De Bont JM, Pieters R Neuro-Oncology 2008 80 6.15 Netherlands Review
12 40 The prognostic-significance of postoperative residual tumor in ependymoma Healey EA, Tarbell NJ Neurosurgery 1991 184 6.13 USA Clinical
21 41 Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group Perilongo G, Madon E Medical and Pediatric Oncology 1997 144 6 Italy Clinical
64 42 Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma Ridley L, Grundy RG Neuro-Oncology 2008 78 6 UK Clinical
84 43 Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial Grundy RG, Machin D European Journal of Cancer 2010 65 5.91 UK Clinical
17 44 Treatment of intracranial ependymomas of children: review of a 15-year experience Rousseau P, Rey A International Journal of Radiation Oncology Biology Physics 1994 154 5.7 France Clinical
36 45 Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials hit 88/89 and hit 91 Timmermann B Bamberg M International Journal of Radiation Oncology Biology Physics 2000 118 5.62 Germany Clinical
33 46 A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors Horn B, Russo C Journal of Pediatric Hematology Oncology 1999 121 5.5 USA Clinical
28 47 Ependymoma: results, prognostic factors and treatment recommendations Mclaughlin MP, Million RR International Journal of Radiation Oncology Biology Physics 1998 126 5.48 USA Clinical
59 48 Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at MD Anderson Cancer Center Akyurek S, Woo SY Journal of Neuro-Oncology 2006 80 5.33 USA Clinical
78 49 Differential expression and prognostic significance of sox genes in pediatric medulloblastoma and ependymoma identified by microarray analysis De Bont JM, Pieters R Neuro-Oncology 2008 69 5.31 Netherlands Basic science
70 50 Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma Tabori U, Hawkins C Journal of Clinical Oncology 2006 76 5.07 Canada Clinical
44 51 Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups Hirose Y, Feuerstein BG American Journal of Pathology 2001 98 4.9 USA Basic science
65 52 Radiation dosimetry predicts iq after conformal radiation therapy in pediatric patients with localized ependymoma Merchant TE, Mulhern RK International Journal of Radiation Oncology Biology Physics 2005 78 4.88 USA Clinical
66 53 Ependymoma: new therapeutic approaches including radiation and chemotherapy Merchant TE, Fouladi M Journal of Neuro-Oncology 2005 78 4.88 USA Clinical
80 54 Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival Lukashova-Von Zangen I, Roggendorf W Acta Neuropathologica 2007 66 4.71 Germany Basic science
95 55 Central nervous system tumors with ependymal features: a broadened spectrum of primarily ependymal differentiation? Lehman NL Journal of Neuropathology And Experimental Neurology 2008 59 4.54 USA Review
89 56 Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue Zacharoulis S, Finlay J Pediatric Blood & Cancer 2007 62 4.43 USA Clinical
25 57 Intracranial ependymoma: long-term results of a policy of surgery and radiotherapy Vanuytsel LJ, Brada M International Journal of Radiation Oncology Biology Physics 1992 128 4.41 UK Clinical
77 58 The high incidence of tumor dissemination in myxopapillary ependymoma in pediatric patients: report of five cases and review of the literature Fassett DR, Kestle JRW Journal of Neurosurgery 2005 70 4.38 USA Clinical
39 59 Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a children’s cancer group study Evans AE, Finlay JL Medical and Pediatric Oncology 1996 106 4.24 USA Clinical
45 60 Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood Needle MN, Phillips PC Cancer 1997 97 4.04 USA Clinical
34 61 Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma Metzger AK, Cogen PH Proceedings of The National Academy of Sciences of the United States of America 1991 120 4 USA Clinical
79 62 A multicenter study of the prognosis and treatment of adult brain ependymal tumors Reni M, Villa E Cancer 2004 68 4 Italy Clinical
19 63 Improved survival in cases of intracranial ependymoma after radiation-therapy: late report and recommendations Salazar OM, Aygun C Journal of Neurosurgery 1983 150 3.95 USA Clinical
81 64 Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma Wolfsberger S, Hainfellner J American Journal of Surgical Pathology 2004 66 3.88 Austria Clinical
37 65 Histologic prognostic factors in ependymoma Schiffer D, Tribolo A Childs Nervous System 1991 116 3.87 Italy Clinical
73 66 Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy van Veelen-Vincent, ML, Renier D Journal of Neurosurgery 2002 72 3.79 Netherlands Clinical
75 67 Influence of tumor grade on time to progression after irradiation for localized ependymoma in children Merchant TE, Kun LE International Journal of Radiation Oncology Biology Physics 2002 71 3.74 USA Clinical
76 68 Preliminary results from a phase II trial of conformal radiation therapy for pediatric patients with localized low-grade astrocytoma and ependymoma Merchant TE, Kun LE International Journal of Radiation Oncology Biology Physics 2002 71 3.74 USA Clinical
29 69 Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients Shaw EG, Earle JD International Journal of Radiation Oncology Biology Physics 1987 126 3.71 USA Clinical
90 70 Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study Massimino M, Madon E International Journal of Radiation Oncology Biology Physics 2004 62 3.65 Italy Clinical
52 71 Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy Merchant TE, Leibel SA Journal of Neurosurgery 1997 85 3.54 USA Clinical
56 72 Treatment of intracranial ependymoma by surgery alone Hukin J, Allen J Pediatric Neurosurgery 1998 81 3.52 USA Clinical
40 73 Postoperative radiotherapy in the management of spinal-cord ependymoma Whitaker SJ, Brada M Journal of Neurosurgery 1991 105 3.5 UK Clinical
24 74 Differential-diagnosis of chordoma, chondroid, and ependymal tumors as aided by anti-intermediate filament antibodies Miettinen M, Virtanen I American Journal of Pathology 1983 129 3.39 Finland Clinical
22 75 Symptomatic subependymoma: report of 21 cases with review of literature Scheithauer BW Journal of Neurosurgery 1978 141 3.28 USA Clinical
91 76 Postoperative radiotherapy for intracranial ependymoma: analysis of prognostic factors and patterns of failure Oya N, Hiraoka M Journal of Neuro-Oncology 2002 62 3.26 Japan Clinical
96 77 Astroblastoma: radiologic-pathologic correlation and distinction from ependymoma Port JD, Pomper MG American Journal of Neuroradiology 2002 59 3.11 USA Clinical
85 78 Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma Reardon DA, Look AT Genes Chromosomes & Cancer 1999 65 2.95 USA Basic science
97 79 Stereotactic radiosurgery for recurrent ependymoma Stafford SL, Schomberg PJ Cancer 2000 59 2.81 USA Clinical
98 80 Pediatric low-grade and ependymal spinal cord tumors Merchant TE, Kun LE Pediatric Neurosurgery 2000 59 2.81 USA Clinical
67 81 Intracranial ependymoma long-term outcome, patterns of failure Kovalic JJ, Roth KA Journal of Neuro-Oncology 1993 78 2.79 USA Clinical
41 82 Subcutaneous sacrococcygeal myxopapillary ependymoma: a clinicopathologic study of 32 cases Helwig EB, Stern JB American Journal of Clinical Pathology 1984 102 2.76 USA Clinical
93 83 Clinicopathologic study of 61 patients with ependymoma including mib-1 immunohistochemistry Prayson RA Annals of Diagnostic Pathology 1999 60 2.73 USA Clinical
60 84 Ependymoma: internal correlations among pathological signs: the anaplastic variant Schiffer D, Vigliani MC Neurosurgery 1991 80 2.67 Italy Clinical
62 85 The role of prophylactic spinal irradiation in localized intracranial ependymoma Vanuytsel L, Brada M International Journal of Radiation Oncology Biology Physics 1991 79 2.63 UK Clinical
94 86 Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma: a report of the children's cancer group Mason WP, Finlay JL Journal of Neuro-Oncology 1998 60 2.61 USA Clinical
53 87 Ependymal and choroid-plexus tumors: cytokeratin and GFAP expression Mannoji H, Becker LE Cancer 1988 84 2.55 Canada Clinical
68 88 Intracranial ependymoma and subependymoma: MR manifestations Spoto GP, Solomon M American Journal of Neuroradiology 1990 78 2.52 USA Clinical
72 89 Intracranial ependymoma in children: analysis of prognostic factors Chiu JK, Shallenberger R Journal of Neuro-Oncology 1992 73 2.52 USA Clinical
86 90 MR characteristics of histopathologic subtypes of spinal ependymoma Kahan H, Bruce JH American Journal of Neuroradiology 1996 63 2.52 USA Clinical
99 91 Tanycytic ependymoma Langford LA, Barre GM Ultrastructural Pathology 1997 59 2.46 USA Clinical
92 92 A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma: a phase-II study Grill J, Hartmann O Pediatric Neurosurgery 1996 61 2.44 France Clinical
43 93 Extra-spinal ependymomas: report of 3 cases Morantz RA, Masterson BJ Journal of Neurosurgery 1979 99 2.36 USA Clinical
20 94 A metastasizing ependymoma of the cauda equina Weiss, L Cancer 1955 148 2.24 USA Clinical
48 95 Delayed distant metastasis from a subcutaneous sacrococcygeal ependymoma: case report, with tissue-culture, ultrastructural observations and review of literature Wolff M, Duby MM Cancer 1972 93 1.9 USA Review
47 96 Secretory ependymoma of filum terminale Miller CA Torack RA Acta Neuropathologica 1970 95 1.86 USA Clinical
51 97 Is subependymoma (subependymal glomerate astrocytoma) an astrocytoma or ependymoma: comparative ultrastructural and tissue-culture study Fu YS, Young HF Cancer 1974 86 1.83 USA Clinical
87 98 Melanin as a component of cerebral gliomas: melanotic cerebral ependymoma Mccloskey JJ, Blacker HM Cancer 1976 63 1.4 USA Clinical
61 99 Ependymoma of the brain: pathologic aspects Svien HJ, Craig WM Neurology 1953 80 1.18 USA Review
71 100 A study of tumors arising from ependymal cells Bailey P Archives of Neurology And Psychiatry 1924 75 0.77 USA Clinical